FDA report on RU-486 abortions: 14 maternal deaths and 2,207 adverse effects
An FDA report which was released in mid-July shows that there has been a rise in the number of women who have experienced adverse effects after taking RU-486. In the U.S., 14 women have died and 2,207 experienced adverse effects after using the drug. 612 women required hospitalization, and other complications included: blood loss significant enough to require transfusion, and infections. As of April 2011, approximately 1.52 million women have used this abortion drug.
“Women developing infections from usage of the RU 486 abortion drug experienced endometritis (involving the lining of the womb), pelvic inflammatory disease (involving the nearby reproductive organs such as the fallopian tubes or ovaries), and pelvic infections with sepsis (a serious systemic infection that has spread beyond the reproductive organs).”1
The numbers released by the FDA also reveals that abortion businesses are still misusing the abortion drug. Despite the FDA indicating, “Administration of mifepristone and misoprostol is contraindicated in patients with confirmed or suspected ectopic pregnancy (a pregnancy outside the uterus,” the abortion drug was misused and given to women in 58 cases where they had an ectopic pregnancy, a pregnancy outside of the uterus.
A study in England revealed that women complained of pain and emotional distress following a RU-486 chemical abortion and the passing of the body of the dead baby.
For more information, go to: